
Vascular Medicine - Physician @chudelareunion - Ex-Thrombosis Fellow @mcgillu - Mum of boys 💪🏼
France
Joined January 2021
- Tweets29
- Following129
- Followers41
- Likes135
Benzidia Ilham retweeted
Major scientific highlight from #ISTH2026 in Paris with simultaneous publication in @JAMA_current
The RCT demonstrated that a diagnostic strategy using the YEARS algorithm in patients with cancer and suspected PE was as safe as using CTPA only, and decreased the need of diagnostic imaging by 22%.
jamanetwork.com/journals/jam…
Benzidia Ilham retweeted
🎉 Congratulations to Dr. @sudeeppappur and the entire #EPCATIII team!
A true highlight of #ISTH2026 in Paris: a Late-Breaking Abstract with simultaneous publication in @NEJM.
Practice-changing results showing that aspirin alone after total hip or knee arthroplasty was noninferior to an initial 5-day course of rivaroxaban followed by aspirin for preventing symptomatic VTE, with no clinically meaningful difference in bleeding.
nejm.org/doi/full/10.1056/NE…
@ThrombosisCan @canvector @isth
Benzidia Ilham retweeted
🚨 Nouveau tuto #ENCCardiologie !
👩⚕️ Dr @BenzidiaI vous montre comment faire un Doppler artériel de débrouillage.
👉 Vidéo ici : enc-cardiologie.fr/videos/tu…
👍 Like & Retweet si vous trouvez ça utile!
@fedecardio
Benzidia Ilham retweeted
Glad to share link to our study showing #DOAC was as safe and effective as #VKA in our patient population with #CTEPH, authors.elsevier.com/a/1hPsv…
Thanks to authors @SusanRKahn1 @BenzidiaI , Dr. D. Langleben, Dr JF Morin, Dr. A Abualsaud, Dr. C Robitaille, L. Lesenko and L. MacDonald
Benzidia Ilham retweeted
Important to have more data on the safety of #DOACs in #CTEPH
N=205
VTE rate 1.10 %/person-year on VKA and 0.32 %/person-year ON DOAC (P = 0.21).
Total bleeding on VKA (2.52 %/person-year) and DOAC (2.52 %/person-year).
sciencedirect.com/science/ar…
@DocHirsch
Benzidia Ilham retweeted
A wonderful reunion this evening of past and current fellows Thrombosis JGH CETAC Montreal #ISTH2023
Benzidia Ilham retweeted
New #JACCHF SOTA review builds on the recently published @ACCinTouch #HFpEF ECDP by integrating contemporary data from recent randomized trials to provide a contemporary framework for Dx & evidence-based Tx of pts w/ HFpEF. https://teapawt.net/t.co/EflN1hnqtQ
#CardioTwitter #HeartFailure
Benzidia Ilham retweeted
IPDMA on diagnostic work-up for suspected acute #pulmonaryembolism during #pregnancy: very limited yield of CUS for DVT, esp in women without leg symptoms jthjournal.org/article/S1538… @Erik_Klok_MD @fniainle @grelegal @MathildeN1977
Benzidia Ilham retweeted
ASA seems to be non-inferior to LMWH in preventing death and associated with low incidence of VTE in patients with pelvic or acetabular fracture or extremity fractures needing surgery #MedTwitter
nejm.org/doi/full/10.1056/NE…
@canvector @ThrombosisCan
Benzidia Ilham retweeted
Dr. @NicolettaRivaMD presented the results of the RIVASVT-100 pilot study at #ASH21. Rivaroxaban seems to have good efficacy and safety profiles for the management of splanchnic vein thrombosis in non-cirrhotic, non-cancer patients.
Benzidia Ilham retweeted
A fantastic week on thrombosis consult service! Thank you Emma, Wassim, Emma, Leon, and Saman!! @WBedrouni @BenzidiaI teapawt.net/VTagalakis/status/1469…
Benzidia Ilham retweeted
New article: Patients with #gastrointestinal #cancer using edoxaban 💊are at risk of gastrointestinal #bleeding Bosch et al @MarcCarrier1 @MiddeldorpS @VerhammePeter @amsterdamumc show advanced cancer and hemoglobin <10 g/dl▶️ bleeding
https://teapawt.net/t.co/UlWAKHWwXY
Benzidia Ilham retweeted
The CETAC team at @LadyDavisJGH and @CIUSSS_COMTL wish all a clot-free #WTDay21 and a happy 200th bday to Virchow! @VTagalakis @blostein_d @DocHirsch @MKoolian @RodgerMarc @BenzidiaI @Pharmacist_MTL @HelenM86MTL @NikkiKampouris



















